![IGF2-tagging of GAA promotes full correction of murine Pompe disease at a clinically relevant dosage of lentiviral gene therapy: Molecular Therapy - Methods & Clinical Development IGF2-tagging of GAA promotes full correction of murine Pompe disease at a clinically relevant dosage of lentiviral gene therapy: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/b22d7d19-d22d-41c6-8f98-128ee409deaf/fx1_lrg.jpg)
IGF2-tagging of GAA promotes full correction of murine Pompe disease at a clinically relevant dosage of lentiviral gene therapy: Molecular Therapy - Methods & Clinical Development
![IJMS | Free Full-Text | From Acid Alpha-Glucosidase Deficiency to Autophagy: Understanding the Bases of POMPE Disease IJMS | Free Full-Text | From Acid Alpha-Glucosidase Deficiency to Autophagy: Understanding the Bases of POMPE Disease](https://pub.mdpi-res.com/ijms/ijms-24-12481/article_deploy/html/images/ijms-24-12481-ag.png?1691238104)
IJMS | Free Full-Text | From Acid Alpha-Glucosidase Deficiency to Autophagy: Understanding the Bases of POMPE Disease
Bioactive Materials for Bone Regeneration: Biomolecules and Delivery Systems | ACS Biomaterials Science & Engineering
![Lentiviral gene therapy prevents anti-human acid α-glucosidase antibody formation in murine Pompe disease - ScienceDirect Lentiviral gene therapy prevents anti-human acid α-glucosidase antibody formation in murine Pompe disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S232905012200064X-fx1.jpg)